ClinicalTrials.gov
public full text
Public Domain
Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis
This is a phase Ib study to investigate the safety, pharmacokinetics and preliminary efficacy of ginsenoside compound K (GCK) tablets in patients with rheumatoid arthritis. This study is to be run in China involving 10-12 sites. It will enroll approximately 240 patients to ensure 128 randomized with active rheumatoid arthritis. The treatment period is 12 weeks and total study duration per patient is approximately 14 weeks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF)#1009026
- Efficacy of Iocide Oral Rinse Against Gingival Inflammation#868380
- A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Rheumatoid Arthritis#913610
- Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma#845148
- First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid Arthritis#1072348
Record · ID 874226
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive